FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration

VJr éronique Frattini, Federica Pisati, Maria Carmela Speranza, Pietro Luigi Poliani, Gianmaria Frigé, Gabriele Cantini, Dimos Kapetis, Manuela Cominelli, Alessandra Rossi, Gaetano Finocchiaro, Serena Pellegatta

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The transcription factor FOXP3 plays an essential role in regulatory T cell development and function. In addition, it has recently been identified as a tumor suppressor in different cancers. Here, we report that FOXP3 is expressed in normal brain but stronglydown-regulated in glioblastoma (GB) and in corresponding GB stem-like cells growing in culture as neurospheres (GB-NS), as evaluatedby real time-PCR and confirmed by immunohistochemistry on an independent set of GB. FOXP3 expression was higher in low-grade gliomasthan in GB. Interestingly, we also found that neurosphere generation, a feature present in 58% of the GB that we examined, correlated with lower expression of FOXP3 and shorter patient survival. FOXP3 silencing in one GB-NS expressing measurable levels of the genecaused a significant increase in proliferation and migration as well as highly aggressive growth in xenografts. Conversely, FOXP3 over-expression impaired GB-NS migration and proliferation in vitro. We also demonstrated using ChiP that FOXP3 is a transcriptional regulator of p21 and c-MYC supporting the idea that dysregulated expression of these factors is a major mechanism of tumorigenesis driven by the loss of FOXP3 expression in gliomas. These findings support the assertion that FOXP3 exhibits tumor suppressor activity in glioblastomas.

Original languageEnglish
Pages (from-to)1146-1157
Number of pages12
JournalOncotarget
Volume3
Issue number10
Publication statusPublished - 2012

Fingerprint

Glioblastoma
Neoplasms
Regulatory T-Lymphocytes
Heterografts
Glioma
Real-Time Polymerase Chain Reaction
Carcinogenesis
Transcription Factors
Stem Cells
Immunohistochemistry
Survival
Brain
Growth

Keywords

  • FOXP3
  • Glioblastoma
  • Migration
  • Neurospheres
  • Proliferation

ASJC Scopus subject areas

  • Oncology

Cite this

Frattini, VJ. É., Pisati, F., Speranza, M. C., Poliani, P. L., Frigé, G., Cantini, G., ... Pellegatta, S. (2012). FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration. Oncotarget, 3(10), 1146-1157.

FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration. / Frattini, VJr éronique; Pisati, Federica; Speranza, Maria Carmela; Poliani, Pietro Luigi; Frigé, Gianmaria; Cantini, Gabriele; Kapetis, Dimos; Cominelli, Manuela; Rossi, Alessandra; Finocchiaro, Gaetano; Pellegatta, Serena.

In: Oncotarget, Vol. 3, No. 10, 2012, p. 1146-1157.

Research output: Contribution to journalArticle

Frattini, VJÉ, Pisati, F, Speranza, MC, Poliani, PL, Frigé, G, Cantini, G, Kapetis, D, Cominelli, M, Rossi, A, Finocchiaro, G & Pellegatta, S 2012, 'FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration', Oncotarget, vol. 3, no. 10, pp. 1146-1157.
Frattini VJÉ, Pisati F, Speranza MC, Poliani PL, Frigé G, Cantini G et al. FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration. Oncotarget. 2012;3(10):1146-1157.
Frattini, VJr éronique ; Pisati, Federica ; Speranza, Maria Carmela ; Poliani, Pietro Luigi ; Frigé, Gianmaria ; Cantini, Gabriele ; Kapetis, Dimos ; Cominelli, Manuela ; Rossi, Alessandra ; Finocchiaro, Gaetano ; Pellegatta, Serena. / FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration. In: Oncotarget. 2012 ; Vol. 3, No. 10. pp. 1146-1157.
@article{e2aeb395f059481f928a32be9e4763cc,
title = "FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration",
abstract = "The transcription factor FOXP3 plays an essential role in regulatory T cell development and function. In addition, it has recently been identified as a tumor suppressor in different cancers. Here, we report that FOXP3 is expressed in normal brain but stronglydown-regulated in glioblastoma (GB) and in corresponding GB stem-like cells growing in culture as neurospheres (GB-NS), as evaluatedby real time-PCR and confirmed by immunohistochemistry on an independent set of GB. FOXP3 expression was higher in low-grade gliomasthan in GB. Interestingly, we also found that neurosphere generation, a feature present in 58{\%} of the GB that we examined, correlated with lower expression of FOXP3 and shorter patient survival. FOXP3 silencing in one GB-NS expressing measurable levels of the genecaused a significant increase in proliferation and migration as well as highly aggressive growth in xenografts. Conversely, FOXP3 over-expression impaired GB-NS migration and proliferation in vitro. We also demonstrated using ChiP that FOXP3 is a transcriptional regulator of p21 and c-MYC supporting the idea that dysregulated expression of these factors is a major mechanism of tumorigenesis driven by the loss of FOXP3 expression in gliomas. These findings support the assertion that FOXP3 exhibits tumor suppressor activity in glioblastomas.",
keywords = "FOXP3, Glioblastoma, Migration, Neurospheres, Proliferation",
author = "Frattini, {VJr {\'e}ronique} and Federica Pisati and Speranza, {Maria Carmela} and Poliani, {Pietro Luigi} and Gianmaria Frig{\'e} and Gabriele Cantini and Dimos Kapetis and Manuela Cominelli and Alessandra Rossi and Gaetano Finocchiaro and Serena Pellegatta",
year = "2012",
language = "English",
volume = "3",
pages = "1146--1157",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "10",

}

TY - JOUR

T1 - FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration

AU - Frattini, VJr éronique

AU - Pisati, Federica

AU - Speranza, Maria Carmela

AU - Poliani, Pietro Luigi

AU - Frigé, Gianmaria

AU - Cantini, Gabriele

AU - Kapetis, Dimos

AU - Cominelli, Manuela

AU - Rossi, Alessandra

AU - Finocchiaro, Gaetano

AU - Pellegatta, Serena

PY - 2012

Y1 - 2012

N2 - The transcription factor FOXP3 plays an essential role in regulatory T cell development and function. In addition, it has recently been identified as a tumor suppressor in different cancers. Here, we report that FOXP3 is expressed in normal brain but stronglydown-regulated in glioblastoma (GB) and in corresponding GB stem-like cells growing in culture as neurospheres (GB-NS), as evaluatedby real time-PCR and confirmed by immunohistochemistry on an independent set of GB. FOXP3 expression was higher in low-grade gliomasthan in GB. Interestingly, we also found that neurosphere generation, a feature present in 58% of the GB that we examined, correlated with lower expression of FOXP3 and shorter patient survival. FOXP3 silencing in one GB-NS expressing measurable levels of the genecaused a significant increase in proliferation and migration as well as highly aggressive growth in xenografts. Conversely, FOXP3 over-expression impaired GB-NS migration and proliferation in vitro. We also demonstrated using ChiP that FOXP3 is a transcriptional regulator of p21 and c-MYC supporting the idea that dysregulated expression of these factors is a major mechanism of tumorigenesis driven by the loss of FOXP3 expression in gliomas. These findings support the assertion that FOXP3 exhibits tumor suppressor activity in glioblastomas.

AB - The transcription factor FOXP3 plays an essential role in regulatory T cell development and function. In addition, it has recently been identified as a tumor suppressor in different cancers. Here, we report that FOXP3 is expressed in normal brain but stronglydown-regulated in glioblastoma (GB) and in corresponding GB stem-like cells growing in culture as neurospheres (GB-NS), as evaluatedby real time-PCR and confirmed by immunohistochemistry on an independent set of GB. FOXP3 expression was higher in low-grade gliomasthan in GB. Interestingly, we also found that neurosphere generation, a feature present in 58% of the GB that we examined, correlated with lower expression of FOXP3 and shorter patient survival. FOXP3 silencing in one GB-NS expressing measurable levels of the genecaused a significant increase in proliferation and migration as well as highly aggressive growth in xenografts. Conversely, FOXP3 over-expression impaired GB-NS migration and proliferation in vitro. We also demonstrated using ChiP that FOXP3 is a transcriptional regulator of p21 and c-MYC supporting the idea that dysregulated expression of these factors is a major mechanism of tumorigenesis driven by the loss of FOXP3 expression in gliomas. These findings support the assertion that FOXP3 exhibits tumor suppressor activity in glioblastomas.

KW - FOXP3

KW - Glioblastoma

KW - Migration

KW - Neurospheres

KW - Proliferation

UR - http://www.scopus.com/inward/record.url?scp=84872821245&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872821245&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 1146

EP - 1157

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 10

ER -